Skip to main content

News

By Dean Koh | 04:30 am | May 20, 2020
Wysa’s chatbot uses CBT and engages users in meditation, breathing yoga and aims to help people build resilience skills.
By Dave Muoio | 04:57 pm | May 19, 2020
Alongside the purchase and service launch, the digital health company also shared news of a $57 million investment from Perceptive Advisors.
By Laura Lovett | 04:35 pm | May 19, 2020
The bots are integrated with the EHR and can tell patients when they should expect the doctor and what labs have been ordered. 
By Dave Muoio | 12:40 pm | May 19, 2020
The consumer-facing digital platform for health testing was forced to pump the brakes on a similar offering roughly two months ago.
By Laura Lovett | 10:55 am | May 19, 2020
Customers will now be able to use the services to get eczema treatment, as well as prescription antiperspirant and dandruff shampoo.
By Dean Koh | 03:29 am | May 19, 2020
Researchers from SMART’s AMR IRG, NTU and MIT are working together to develop a rapid serological test and a rapid diagnostic test (RDT), based on protein detection.  
By Piers Ford | 02:18 am | May 19, 2020
Getting defibrillators to cardiac arrest patients as quickly as possible is a priority for emergency services everywhere. In one area of Sweden, 112 call takers will soon be able to dispatch a drone at the same time as an ambulance to drop a defibrillator near the patient if they suspect a cardiac arrest.
By Dean Koh | 01:00 am | May 19, 2020
The company is building the world's largest RWE platform in behavioral health and chronic diseases to expand data-driven, evidence-based care for people managing behavioral health conditions.
By HIMSS Media | 06:02 pm | May 15, 2020
The COVID-19 pandemic has deeply affected us all. To honor those who have been lost and those who are working so hard to keep us well, HIMSS and its media brands will observe a digital day of silence and appreciation on May 18.  
By Laura Lovett | 05:14 pm | May 15, 2020
Fitbit's CEO James Park told CNBC that the company will be submitting its technology to the FDA soon.